S100A4 and neoplasm: Low FSP/S100A4 expression has been correlated with improved disease free survival (Andersen et al., 2004), while data showed high nuclear S100A4 expression correlated with worse overall survival (Jurmeister et al., 2019); however, these studies do not differentiate between CAF and tumor S100A4 expression.